School of Pharmacy, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham United Kingdom.
College of Pharmacy and Health Sciences, Western New England University, United States; Xuangya Hospital of Central South University, Hunan, China.
Res Social Adm Pharm. 2022 Mar;18(3):2524-2528. doi: 10.1016/j.sapharm.2021.05.004. Epub 2021 May 13.
The COVID-19 pandemic has met international health systems with a low level of preparedness and emergency response. While the emergence of effective vaccines has offered the Governments, scientific communities, and members of the public a possible way out of the pandemic, effective pharmacotherapy, including immunotherapy for COVID-19 prevention and treatment, are yet to be established. Internationally, this has led to a surge in the demand and supply of many complementary and alternative medicines (CAM) and practices. Recent studies have shown increasing CAM information requests made to pharmacists and other healthcare staff from members of public and patients aimed at prevention, symptoms relief or treatment of COVID-19. In this context, it is imperative that healthcare professionals, including pharmacists, are acquainted with current practices, policies, and research in relation to CAM use in COVID-19. This narrative commentary will provide an update on global practices, policies and research in regards to CAM use in the context of COVID-19. Healthcare professionals' understanding of popular CAMs and those tipped for potential benefits in COVID-19, patient and consumer behaviors in relation to CAM use; and healthcare professionals' awareness of cultural, religious, and self-care practices associated with CAM use are imperative to inform effective communication and counselling practices and promote evidence based self-care when patients present for advice. This narrative provides relevant discussions specific to different continents and regions historically linked to diverse CAM practices.
COVID-19 大流行使国际卫生系统的准备和应急能力不足。虽然有效的疫苗的出现为政府、科学界和公众提供了一种走出大流行的可能途径,但有效的药物治疗,包括 COVID-19 的预防和治疗免疫疗法,尚未建立。在国际上,这导致对许多补充和替代药物(CAM)和实践的需求和供应激增。最近的研究表明,公众和患者向药剂师和其他医护人员提出的有关 COVID-19 预防、缓解症状或治疗的 CAM 信息请求不断增加。在这种情况下,包括药剂师在内的医护人员必须了解与 COVID-19 中 CAM 使用相关的当前实践、政策和研究。本叙述性评论将提供有关 COVID-19 背景下 CAM 使用的全球实践、政策和研究的最新信息。医护人员对流行 CAM 和那些可能对 COVID-19 有益的 CAM 的了解、患者和消费者在 CAM 使用方面的行为;以及医护人员对与 CAM 使用相关的文化、宗教和自我保健实践的认识,对于提供有效的沟通和咨询实践以及促进基于证据的自我保健非常重要,当患者寻求建议时。本叙述提供了与历史上与各种 CAM 实践相关的不同大陆和地区相关的具体讨论。